It has long been recognized that parenteral immunization can boost both mucosal and systemic immune responses that protect against cholera in humans residing in cholera-endemic areas, possibly through boosting of pre-existing immune responses, including IgM and secretory IgA in intestinal secretions, milk and saliva [55], [56], [57], [58]. The gene discussed is CD40LG; the disease is vibrio infectious disease.